Valuation: Rapid Dose Therapeutics Corp.

Market Cap 15.01M 10.62M 9.32M 8.8M 8.02M 1.02B 15.12M 105M 40.78M 520M 39.86M 39M 1.67B P/E 2025
-3.92x
P/E 2026 -5.88x
Enterprise Value 20.32M 14.37M 12.61M 11.91M 10.85M 1.38B 20.46M 143M 55.2M 704M 53.96M 52.79M 2.26B EV / Sales 2025
11.8x
EV / Sales 2026 9.23x
Free-Float
82.98%
Yield 2025 *
-
Yield 2026 -
07-30 Rapid Dose Therapeutics Corp. Reports Earnings Results for the First Quarter Ended May 31, 2026 CI
07-29 Rapid Dose Therapeutics Corp And Bodhi Health Inc Expand Distribution And Sales Of CurcuWIN QuickStrip Curcumin Across Canada CI
07-06 Rapid Dose Therapeutics Corp. and Global Nicotine Leader Extend Strategic Collaboration for Quickstrip Dissolvable Oral Nicotine Strip Technology CI
06-29 Rapid Dose Therapeutics Corp. Reports Earnings Results for the Full Year Ended February 28, 2026 CI
06-28 Rapid Dose Therapeutics Corp. Auditor Raises 'Going Concern' Doubt CI
04-13 Rapid Dose Therapeutics Corp Advances Pharmaceutical Manufacturing Expansion with Burlington Facility Upgrades Targeting Global Medical Markets CI
04-06 Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt MT
03-05 Rapid Dose Therapeutics And Aavishkar Oral Strips Secure Patent For Quickstrip Nicotine Bilayer Oral Film CI
02-23 Rapid Dose Therapeutics Corp. Advances Cannabinoid Research and Clinical Evaluation of QuickStrip Platform CI
02-10 Rapid Dose Therapeutics Corp. Launches QuickStrip? Medical Cannabis for Patients in Brazil CI
01-29 Rapid Dose Therapeutics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2025 CI
30/10/25 Rapid Dose Therapeutics Corp. Reports Earnings Results for the Second Quarter and Six Months Ended August 31, 2025 CI
05/08/25 Rapid Dose Therapeutics Corp. Submits QuickStrip®? Nicotine Product for Health Canada CI
3 months+543.94%
6 months+21.43%
Current year-5.56%
1 month 0.08
Extreme 0.085
0.08
Current year 0.01
Extreme 0.0132
0.12
1 year 0.01
Extreme 0.006
0.15
3 years 0
Extreme 0.0021
0.39
5 years 0
Extreme 0.0004
1.11
10 years 0
Extreme 0
1.11
Manager TitleAgeSince
Chief Executive Officer - 02/05/2017
Director of Finance/CFO - 27/02/2020
Corporate Officer/Principal - 05/12/2019
Director TitleAgeSince
Chairman - -
Director/Board Member - 05/08/2024
Director/Board Member - 12/08/2020
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 10.61M
+105.06%+117.14%+441.65%+1,036.45% 114M
+4.81%-2.85%-17.15%-44.04% 97.54M
+0.45%+1.37%-19.32%-65.30% 82.32M
-1.19%-1.78%+41.88%+26.72% 75.82M
Average +21.73%-0.85%+111.76%+238.46% 92.38M
Weighted average by Cap. +32.44%-0.51%+135.83%+298.64%

Financials

2025 2026
Net sales 2.09M 1.47M 1.29M 1.22M 1.11M 141M 2.1M 14.63M 5.67M 72.22M 5.54M 5.42M 232M 2.77M 1.96M 1.72M 1.63M 1.48M 188M 2.79M 19.45M 7.53M 96.05M 7.36M 7.21M 309M
Net income -5.4M -3.82M -3.35M -3.17M -2.89M -366M -5.44M -37.91M -14.68M -187M -14.35M -14.04M -602M -3.39M -2.4M -2.1M -1.99M -1.81M -230M -3.41M -23.78M -9.21M -117M -9M -8.81M -377M
Net Debt 2.59M 1.83M 1.61M 1.52M 1.38M 176M 2.61M 18.16M 7.03M 89.67M 6.88M 6.73M 288M 5.31M 3.76M 3.3M 3.11M 2.84M 360M 5.35M 37.25M 14.43M 184M 14.1M 13.8M 591M
Logo Rapid Dose Therapeutics Corp.
Rapid Dose Therapeutics Corp. is a Canadian biotechnology company. It provides disruptive drug delivery technologies designed to improve patient outcomes. Its flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient. It has one operating segment comprising production, distribution, research, and the provision of technical services for the delivery of oral thin film strips containing active ingredients. It offers over-the-counter and pharmaceutical drug delivery solutions. Its QuickStrip Energy delivers energizing caffeine. Its QuickStrip B12 delivers vitamin B12 to the system, assisting with metabolism and physical energy. Its QuickStrip Sleep delivers melatonin to the system, inducing natural and healthy sleep. QuickStrip Lidocaine is its dental product.
Employees
-